Literature DB >> 950577

International collaborative study of the spinal muscular atrophies. Part 1. Analysis of clinical and laboratory data.

A E Emery, I Hausmanowa-Petrusewicz, A M Davie, S Holloway, R Skinner, J Borkowska.   

Abstract

There is considerable variation in age of onset, though in over three-quarters of cases onset is before 4 years of age. A febrile episode, often of viral origin, may be present at the time of onset and might possibly be of aetiological significance, perhaps by precipitating the disease in a genetically predisposed individual. Reduced fetal movements and floopiness at birth are present in about one third of those cases where the onset is in early childhood. It would seem that when the onset is before 4 years of age, and particularly if the child has never been able to sit without support, the prognosis is much worse than in cases where the onset is after the age of 4 years. The proximal limb muscles are predominantly affected and muscle tone is usually reduced but pseudohypertrophy is uncommon. Rarely are the cranial nerves affected. Muscle fasiculations are present in about half the cases. Almost 10% of cases appear to be mentally retarded. With regard to the EMG findings, spontaneous activity, reduced full effort pattern increased potential amplitude and duration and increased motor unit territory appear to be the most reliable diagnostic criteria. Routine histological evidence of neurogenic atrophy seems to be a more reliable diagnostic criterion than muscle histochemistry. However, this may be only reflect the way in which the data were selected, that is, from cases where a muscle biopsy showed evidence of neurogenic atrophy on routine histology. Finally the serum level of creatine kinase is rarely very high and in more than half the cases it is normal. The CSF chemistry is always normal.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 950577     DOI: 10.1016/0022-510x(76)90082-4

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  9 in total

1.  Population data on acute infantile and chronic childhood spinal muscular atrophy in Warsaw.

Authors:  A W Spiegler; I Hausmanowa-Pertrusewicz; J Borkowska; A Kłopocka
Journal:  Hum Genet       Date:  1990-07       Impact factor: 4.132

2.  A clinical, epidemiological and genetic study of hereditary motor neuropathies in Benghazi, Libya.

Authors:  K Radhakrishnan; A K Thacker; J C Maloo
Journal:  J Neurol       Date:  1988-09       Impact factor: 4.849

3.  Progressive bulbar paralysis in childhood: a case report.

Authors:  G F Perticoni; T A Cantisani; H Fisher
Journal:  Ital J Neurol Sci       Date:  1983-04

4.  A clinico-pathological study of the floppy infant syndrome.

Authors:  B B Sawhney; I V Allen; M W Swallow
Journal:  Ir J Med Sci       Date:  1978-05       Impact factor: 1.568

5.  Prospective study of gross motor development in children with SMA type II.

Authors:  R Bono; M Inverno; G Botteon; E Iotti; M Estienne; A Berardinelli; G Lanzi; E Fedrizzi
Journal:  Ital J Neurol Sci       Date:  1995-05

6.  Clinical study of proximal spinal muscular atrophy. Report on 89 cases.

Authors:  P Tonali; S Servidei; A Uncini; D Restuccia; G Galluzzi
Journal:  Ital J Neurol Sci       Date:  1984-12

7.  The next generation of population-based spinal muscular atrophy carrier screening: comprehensive pan-ethnic SMN1 copy-number and sequence variant analysis by massively parallel sequencing.

Authors:  Yanming Feng; Xiaoyan Ge; Linyan Meng; Jennifer Scull; Jianli Li; Xia Tian; Tao Zhang; Weihong Jin; Hanyin Cheng; Xia Wang; Mari Tokita; Pengfei Liu; Hui Mei; Yue Wang; Fangyuan Li; Eric S Schmitt; Wei V Zhang; Donna Muzny; Shu Wen; Zhao Chen; Yaping Yang; Arthur L Beaudet; Xiaoming Liu; Christine M Eng; Fan Xia; Lee-Jun Wong; Jinglan Zhang
Journal:  Genet Med       Date:  2017-01-26       Impact factor: 8.822

8.  Decay in survival motor neuron and plastin 3 levels during differentiation of iPSC-derived human motor neurons.

Authors:  María G Boza-Morán; Rebeca Martínez-Hernández; Sara Bernal; Klaus Wanisch; Eva Also-Rallo; Anita Le Heron; Laura Alías; Cécile Denis; Mathilde Girard; Jiing-Kuan Yee; Eduardo F Tizzano; Rafael J Yáñez-Muñoz
Journal:  Sci Rep       Date:  2015-06-26       Impact factor: 4.379

Review 9.  Therapy development for spinal muscular atrophy: perspectives for muscular dystrophies and neurodegenerative disorders.

Authors:  Sibylle Jablonka; Luisa Hennlein; Michael Sendtner
Journal:  Neurol Res Pract       Date:  2022-01-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.